Literature DB >> 22395473

Q48P mutation in the hMLH1 gene associated with Lynch syndrome in three Hungarian families.

Miklós Tanyi1, Judit Olasz, Janos L Tanyi, László Tóth, Péter Antal-Szalmás, Tamás Bubán, Csilla András, Hilda Urbancsek, Zoltán Garami, Orsolya Csuka, László Damjanovich.   

Abstract

Lynch syndrome (Hereditary nonpolyposis colorectal cancer, HNPCC) is an inherited disease with variable phenotype causing the development of colon cancer and other malignancies. The basis of the disease is believed to be the mismatch repair gene mutations. Genetic screening has been performed among the patients who have undergone surgery for colon cancer at the University of Debrecen, Department of Surgery. Tumor samples of the screened patients were submitted to immunohistochemistry on hMLH1, hMSH2 and hMSH6 genes, microsatellite instability testing, followed by sequencing and multiple ligation dependent probe amplification. Three families were identified with the missense mutation c.143A>C (p.Q48P) of hMLH1 gene. In one of the families a segregation analysis of this particular variant was also accomplished. The segregation analysis revealed a clear correlation between the tumor cases and the occurrence of this mutation. However, none of the analyzed 100 healthy controls demonstrated the same aberration. There is only one published evidence in the literature about the presence of this rare variant in any population. The Gln to Pro switch in the ATPase domain, a conservative region of the hMLH1 gene, creates significant changes in the protein structure. These results indicate that this mutation is the abnormality responsible for the patients' phenotype and it is feasible that this particular aberration occurs more frequently among Hungarian Lynch syndrome patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395473     DOI: 10.1007/s10689-012-9515-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  27 in total

Review 1.  The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

Authors:  D C Chung
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

2.  A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome).

Authors:  A G Thorson; J A Knezetic; H T Lynch
Journal:  Dis Colon Rectum       Date:  1999-01       Impact factor: 4.585

3.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 4.  Genetic predisposition to colorectal cancer.

Authors:  Albert de la Chapelle
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

Review 5.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  Difficulties in recognizing families with Hereditary Non-polyposis Colorectal Carcinoma. Presentation of 4 families with proven mutation.

Authors:  M Tanyi; J Olasz; E Kámory; O Csuka; J L Tanyi; Z Ress; L Damjanovich
Journal:  Eur J Surg Oncol       Date:  2008-03-04       Impact factor: 4.424

7.  Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.

Authors:  Miklós Tanyi; Judith Olasz; Géza Lukács; Orsolya Csuka; László Tóth; Zoltán Szentirmay; Zsuzsa Ress; Zsolt Barta; János L Tanyi; László Damjanovich
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

8.  Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.

Authors:  Renée C Niessen; Robert M W Hofstra; Helga Westers; Marjolijn J L Ligtenberg; Krista Kooi; Paul O J Jager; Marloes L de Groote; Trijnie Dijkhuizen; Maran J W Olderode-Berends; Harry Hollema; Jan H Kleibeuker; Rolf H Sijmons
Journal:  Genes Chromosomes Cancer       Date:  2009-08       Impact factor: 5.006

9.  An intronic mutation in MLH1 associated with familial colon and breast cancer.

Authors:  F Bianchi; M Raponi; F Piva; A Viel; I Bearzi; E Galizia; R Bracci; L Belvederesi; C Loretelli; C Brugiati; F Corradini; D Baralle; R Cellerino
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

10.  Extensive molecular screening for hereditary non-polyposis colorectal cancer.

Authors:  B Dieumegard; S Grandjouan; J C Sabourin; M L Le Bihan; I Lefrère; J P Pignon; P Rougier; P Lasser; J Bénard; D Couturier; B Bressac-de Paillerets
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

View more
  1 in total

1.  Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.

Authors:  Guo-Li Gu; Xiao-Quan Zhu; Xue-Ming Wei; Li Ren; De-Chang Li; Shi-Lin Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.